Clinical trial
Stem Cell Transplant to Treat Patients With Systemic Sclerosis
NCT00058578 · Baylor College of Medicine, Other · Completed
Key facts
| NCT number | NCT00058578 |
|---|---|
| Title | Stem Cell Transplant to Treat Patients With Systemic Sclerosis |
| Official title | Autologous T-Cell Depleted Peripheral Blood Stem Cell Transplantation for the Treatment of Selected Patients With Systemic Sclerosis |
| Lead sponsor | Baylor College of Medicine, Other |
| Collaborators | The Methodist Hospital Research Institute Center for Cell and Gene Therapy, Baylor College of Medicine |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Systemic Sclerosis |
| Intervention type | Drug, Procedure |
| Interventions | Cyclophosphamide, Mesna, G-CSF, Leukopheresis, Total Body Irradiation |
| Enrollment | 24 |
| Start date | Jun 1, 1999 |
| Completion | Jun 1, 2004 |
| First posted | Apr 9, 2003 |
| Last update posted | Jan 18, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: